跳至主要内容
临床试验/ISRCTN14379650
ISRCTN14379650进行中(未招募)未知

Fatigue in primary biliary cholangitis: factors associated with severity and persistence as future therapeutic targets

niversity Medical Center Hamburg-Eppendorf0 个研究点目标入组 480 人开始时间: 2021年11月5日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
发起方
入组人数
480

研究概览

简要总结

2022 Protocol article in https://pubmed.ncbi.nlm.nih.gov/36600365/ (added 06/01/2023)

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • 1. Clinical diagnosis of PBC (PSC)
  • 2. Sufficient oral and written German language proficiency
  • 3. Provision of written consent

排除标准

  • 1. Advanced cirrhosis (Child Pugh score =8)
  • 2. Decompensated liver disease (autoimmune hepatitis or chronic viral hepatitis B or C)
  • 3. Clinically significant untreated intercurrent medical condition associated with fatigue (i.e. hypothyroidism, anaemia, fibromyalgia, rheumatoid arthritis, systemic lupus erythematosus and manifest depression)
  • 4. Antibiotic treatment during the past 6 weeks (exclusion only in microbiome study)
  • 5. Ongoing participation in clinical trials on fatigue
  • 6. Intercurrent active or latent infection
  • 7. Florid psychosis
  • 8. Substance abuse disorder
  • 9. Acute suicidality

研究者

发起方
niversity Medical Center Hamburg-Eppendorf

相似试验